- Thu., June 18, 1230–1715 Symposium: Retinopathy of prematurity
- Fri., June 19, 1045-1215 Pediatrics I: Ethics, anterior segment and pediatric ophthalmology poster previews
- Fri., June 19, 1330-1500 Pediatrics II: Strabismus, amblyopia and vision screening
- Fri., June 19, 1545-1715 Pediatrics III – Pediatric ophthalmology and strabismus for the comprehensive ophthalmologist
- Sat., June 20, 1045-1215 COS-5 Clinical update: Pediatrics
- Poster presentations
Symposium: Retinopathy of prematurity
Thursday, June 18, 1230–1715
Carson A
OBJECTIVES
At the end of this session, participants will be able to:
- Integrate some of the latest research, particularly on risk factors, into their care of ROP patients
- Apply new knowledge from the Canadian SCREEN-ROP study, into their care of ROP patients
- Demonstrate a solid understanding of the pros and cons of anti-VEGF therapy
- Understand the ethical issues involved in ROP care
GUESTSAnn Hellström |
MODERATORSJane Gardiner |
Schedule
| 1230 | Introduction · Jane Gardiner |
| 1235 | WINROP as a screening tool for ROP · Ann Hellström |
| 1300 | Discussion |
| 1310 | 2nd Prize, COS Award for Excellence in Research Neurodevelopmental outcomes of preterm infants treated with bevacizumab for severe ROP · J. Morin, R. Superstein, T. Luu, L.H. Ospina, F. Lefebvre, M. Simard, V.Shah, S. Shah, E. Kelly |
| 1317 | Review of teleophthalmology screening for ROP at McMaster University · S. Mohaghegh, V. Chaudhary, G. Isaza, J. Barbosa |
| 1324 | Discussion |
| 1330 | SCREEN-ROP: Part 1 · Kourosh Sabri |
| 1350 | Discussion |
| 1400 | Omega 3 and insulin growth factor in ROP · Ann Hellström |
| 1420 | Discussion |
| 1430 | Avastin debate: Pro · Patrick Hamel |
| 1440 | Avastin debate: Con · N.N. Tehrani |
| 1450 | Discussion |
| 1500 | Break |
| 1530 | Introduction · Jane Gardiner |
| 1532 | To inject or not to inject: Ethics, innovation and ROP · Alex Levin |
| 1547 | Discussion |
| 1555 | Involution patterns of type 1 ROP after treatment with intravitreal bevacizumab · K. Mireskandari, M. Isaac, N.N. Tehrani |
| 1602 | Ranibizumab for treatment of type 1 ROP · J.D. Wesolosky, A. Ells, P. Mitchell |
| 1609 | Outcomes following treatment of type 1 ROP with bevacizumab vs. laser: 2-Year follow-up · N.N. Tehrani, M. Isaac, K. Mireskandari |
| 1616 | Discussion |
| 1625 | SWEDROP: A national register including all children screened for ROP in Sweden since 2004 · Ann Hellström |
| 1640 | Discussion |
| 1645 | SCREEN-ROP: Part 2 · Kourosh Sabri |
| 1705 | Discussion |
Canadian Association of Pediatric Ophthalmology and Strabismus
Pediatrics I – Ethics, anterior segment and pediatric ophthalmology poster previews
Friday, June 19, 1045-1215
Carson C
OBJECTIVES
At the end of this session participants will be able to:
- Understand the issues involved in adopting EMRs
- Integrate new therapies and updated information of pediatric glaucoma into patient care
- Become aware of the ethics involved in using novel therapies for unilateral retinoblastoma
GUEST |
MODERATORLuis Ospina |
Schedule
| 1045 | Introduction |
| 1048 | Intracameral use of preservative-free triamcinolone in pediatric cataract · H.A. Khan |
| 1055 | A five-year experience of electronic medical records (EMR) in pediatric ophthalmology and strabismus practice · V. Erraguntla, H. Rattanavong, L. Groff |
| 1102 | Efficacy and safety of cyclosporine topical eye drops in severe allergic keratoconjunctivitis in children · H.A. Khan, Z. Khouqweer |
| 1109 | Ethical considerations of innovative therapy in children with unilateral retinoblastoma · C. McAlister, B.L. Gallie |
| 1116 | Discussion |
| 1123 | The international childhood glaucoma research network classification and registry · Alex Levin |
| 1138 | Discussion |
| 1145 | Poster preview introduction (90 seconds per poster)
|
Canadian Association of Pediatric Ophthalmology and Strabismus
Pediatrics II: Strabismus, amblyopia and vision screening
Friday, June 19, 1330–1500
Carson C
OBJECTIVES
At the end of this session participants will be able to:
- Describe current research in the areas of amblyopia and strabismus
- Integrate Botox into surgical management of strabismus
- Integrate AS-OCT into strabismus management
- Assess examples of Canadian vision screening programs
MODERATOR
Ross Kennedy
Schedule
| 1330 | Introduction |
| 1333 | Factors predicting decompensation in children with accommodative esotropia and high AC/A ratio · Y.N. Chen, A. Mao, I. Makar |
| 1340 | Botulinum toxin in strabismus · V. Pegado |
| 1347 | Factors associated with success in strabismus surgery secondary to thyroid eye disease · I. Golesic, I. Makar |
| 1354 | Discussion |
| 1402 | Myopia and strabismus: An epidemiological analysis · A. Alhaji, G. Laroche |
| 1409 | Pediatric vision screening: How are Ontario primary care physicians doing? · T.D. Le, R.A. Raashid, L. Colpa, J. Noble, A. Ali, A. Wong |
| 1416 | An evidence-based assessment of pediatric vision screening by non-eye care professionals: Moving towards evidence-based practice · K. Sabri, S. Husain, S. Tavassoly, R. Wong, Y. Jin, F. Farrokhyar |
| 1423 | Discussion |
| 1431 | Developmental trajectory of audiovisual integration in children and adults with amblyopia · A. Wong, C. Narinesingh, A. Raashid, H. Goltz |
| 1438 | Accuracy of anterior segment optical coherence tomography (AS-OCT) in localising ocular rectus muscles · S. Kraft, C.S. Ngo, D. Smith |
| 1445 | Behavioral training as new treatment for adult amblyopia: A meta-analysis and systematic review · A. Wong, I. Tsirlin, L. Colpa, H. Goltz |
| 1452 | Discussion |
Canadian Association of Pediatric Ophthalmology and Strabismus
Pediatrics III – Pediatric ophthalmology and strabismus for the comprehensive ophthalmologist
Friday, June 19, 1545–1715
Carson C
OBJECTIVES
At the end of this session participants will be able to:
- Incorporate pediatric eye exam tips into their practice, without missing problems
- Assess and manage ocular surface disease in the pediatric population
- Integrate strabismus surgery into their practice
- Have confidence when dealing with suspected non-accidental injury patients
- Manage post-cataract and refractive surgery diplopia surprises
MODERATOR
Jane A. Gardiner
Schedule
| 1545 | Introduction |
| 1547 | Pediatric eye exam tips and tricks · Michael O’Connor |
| 1556 | Discussion |
| 1559 | Ocular surface disease: Peculiarities in children · Inas Makar |
| 1608 | Discussion |
| 1611 | Strategies for strabismus surgery for the comprehensive ophthalmologist · Roy Cline |
| 1631 | Discussion |
| 1639 | Post-op diplopia surprises after cataract or refractive surgery… 2 quick pre-op tests could have predicted · Robert LaRoche |
| 1648 | Discussion |
| 1651 | Non-accidental Injury: What the comprehensive ophthalmologist should know · Jane Gardiner |
| 1700 | Discussion |
| 1703 | Patient with a lazy eye: Check the whole eye · Vasudha Erraguntla |
| 1712 | Discussion |
Canadian Association of Pediatric Ophthalmology and Strabismus
COS-5 Clinical update: Pediatrics
Saturday, June 20, 1045-1215
Theatre
OBJECTIVES
At the end of this session participants will be able to:
- Integrate current research on ocular genetics and amblyopia into their practice
- Assess the risk factors for retinopathy of prematurity
- Describe the “new science” perpetrated in abusive head trauma legal cases
GUESTS |
MODERATORChristopher Lyons |
Schedule
| 1045 | Introduction · Christopher Lyons |
| 1048 | An update on risk factors for ROP · Ann Hellström |
| 1108 | When should we think of genetic testing for our patients? · Elise Heon |
| 1125 | What’s new and exciting in amblyopia? · Agnes Wong |
| 1145 | The “new science” of abusive head trauma · Alex Levin |
| 1200 | Discussion |
Alex V. Levin, MD
Ann Hellström, MD